483 related articles for article (PubMed ID: 24433203)
21. New aspects of the role of histamine in cardiovascular function: identification, characterization, and potential pathophysiological importance of H3 receptors.
Göthert M; Garbarg M; Hey JA; Schlicker E; Schwartz JC; Levi R
Can J Physiol Pharmacol; 1995 May; 73(5):558-64. PubMed ID: 7585321
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological effects of carcinine on histaminergic neurons in the brain.
Chen Z; Sakurai E; Hu W; Jin C; Kiso Y; Kato M; Watanabe T; Wei E; Yanai K
Br J Pharmacol; 2004 Nov; 143(5):573-80. PubMed ID: 15466447
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological properties of histamine receptor subtypes.
Arrang JM
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):275-81. PubMed ID: 7920174
[TBL] [Abstract][Full Text] [Related]
24. Histaminergic mechanisms involved in the centrally mediated effects of ouabain.
Tackett RL; Holl JE
J Pharmacol Exp Ther; 1980 Dec; 215(3):552-6. PubMed ID: 6108363
[TBL] [Abstract][Full Text] [Related]
25. Identification of a histaminergic circuit in the caudal hypothalamus: an evidence for functional heterogeneity of histaminergic neurons.
Umehara H; Mizuguchi H; Fukui H
Neurochem Int; 2012 Nov; 61(6):942-7. PubMed ID: 22677810
[TBL] [Abstract][Full Text] [Related]
26. [Physiopathology of the migraine attack and mechanisms of action of anti-migraine agents: recent findings in animals].
Mick G
Pathol Biol (Paris); 2000 Sep; 48(7):593-607. PubMed ID: 11072637
[TBL] [Abstract][Full Text] [Related]
27. Histaminergic neurons in the hypothalamic thermoregulatory pathways.
Lomax P; Green MD
Fed Proc; 1981 Nov; 40(13):2741-5. PubMed ID: 6117483
[TBL] [Abstract][Full Text] [Related]
28. Neurochemical evidence for histamine acting as a transmitter in mammalian brain.
Schwartz JC; Barbin G; Garbarg BM; Pollard H; Rose C; Verdiere M
Adv Biochem Psychopharmacol; 1976; 15():111-26. PubMed ID: 15407
[TBL] [Abstract][Full Text] [Related]
29. Basic mechanisms of migraine and its acute treatment.
Edvinsson L; Villalón CM; MaassenVanDenBrink A
Pharmacol Ther; 2012 Dec; 136(3):319-33. PubMed ID: 22939884
[TBL] [Abstract][Full Text] [Related]
30. AQ-0145, a newly developed histamine H3 antagonist, decreased seizure susceptibility of electrically induced convulsions in mice.
Murakami K; Yokoyama H; Onodera K; Iinuma K; Watanabe T
Methods Find Exp Clin Pharmacol; 1995 Nov; 17 Suppl C():70-3. PubMed ID: 8750799
[TBL] [Abstract][Full Text] [Related]
31. Neurogenic inflammation in the context of migraine.
Williamson DJ; Hargreaves RJ
Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
[TBL] [Abstract][Full Text] [Related]
32. (11) C-labeled and (18) F-labeled PET ligands for subtype-specific imaging of histamine receptors in the brain.
Funke U; Vugts DJ; Janssen B; Spaans A; Kruijer PS; Lammertsma AA; Perk LR; Windhorst AD
J Labelled Comp Radiopharm; 2013; 56(3-4):120-9. PubMed ID: 24285318
[TBL] [Abstract][Full Text] [Related]
33. [Subcutaneous histamine in migraine prophylaxis. Initial effects and long-term outcome].
Millán Guerrero R; Trujillo Hernández B; Tene CE
Neurologia; 2006 Mar; 21(2):55-9. PubMed ID: 16525910
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
Esbenshade TA; Fox GB; Krueger KM; Baranowski JL; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan JB; Faghih R; Bennani YL; Williams M; Hancock AA
Biochem Pharmacol; 2004 Sep; 68(5):933-45. PubMed ID: 15294456
[TBL] [Abstract][Full Text] [Related]
35. Involvement of tuberomamillary histaminergic neurons in isoflurane anesthesia.
Luo T; Leung LS
Anesthesiology; 2011 Jul; 115(1):36-43. PubMed ID: 21562401
[TBL] [Abstract][Full Text] [Related]
36. Selective brain region activation by histamine H₃ receptor antagonist/inverse agonist ABT-239 enhances acetylcholine and histamine release and increases c-Fos expression.
Munari L; Provensi G; Passani MB; Blandina P
Neuropharmacology; 2013 Jul; 70():131-40. PubMed ID: 23380305
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
Blumenfeld A; Gennings C; Cady R
Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
[TBL] [Abstract][Full Text] [Related]
38. Activation of orexinergic and histaminergic pathway involved in therapeutic effect of histamine H
Yamamoto K; Okui R; Yamatodani A
Naunyn Schmiedebergs Arch Pharmacol; 2019 Aug; 392(8):925-936. PubMed ID: 30919010
[TBL] [Abstract][Full Text] [Related]
39. [Possible roles of brain histamine H3 receptors and the pharmacology of its ligands].
Onodera K; Watanabe T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):87-102. PubMed ID: 7796325
[TBL] [Abstract][Full Text] [Related]
40. [The histaminergic brain neuron system].
Zimatkin SM; Kuznetsova VB; Anishchik OV
Morfologiia; 2003; 123(2):97-105. PubMed ID: 12891790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
